- Home
- INMB vs EHTH Comparison
INMB vs EHTH Comparison
Compare INMB & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INMB | EHTH |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 46.0M |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | INMB | EHTH |
|---|---|---|
| Price | $1.64 | $1.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $5.40 | $3.33 |
| AVG Volume (30 Days) | ★ 1.2M | 455.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.85 | ★ 71.43 |
| EPS | ★ N/A | N/A |
| Revenue | $50,000.00 | ★ $251,395,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 257.14 | 45.86 |
| 52 Week Low | $1.09 | $1.20 |
| 52 Week High | $3.24 | $5.89 |
Technical Indicators
Market Signals| Indicator | INMB | EHTH |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 35.21 |
| Support Level | $1.23 | $1.21 |
| Resistance Level | $1.76 | $1.58 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 16.00 | 3.49 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.